KalVista Pharmaceuticals (KALV) Exchange Rate Effect (2016 - 2025)
KalVista Pharmaceuticals recorded quarterly Exchange Rate Effect of $2.7 million in Q3 2025, down 19.05% quarter-over-quarter from $3.4 million in Q2 2025, and up 2227.35% year-over-year from $117000.0 in Q3 2024.
KalVista Pharmaceuticals' Exchange Rate Effect history runs 10 years deep, the most recent figure standing at $2.7 million for Q3 2025.
- In Q3 2025, Exchange Rate Effect rose 2227.35% year-over-year to $2.7 million; the TTM figure through Jul 2025 stood at $6.6 million (up 660.25% YoY), while the FY2025 annual figure was $2.6 million, up 317.56% from the prior year.
- Exchange Rate Effect came in at $2.7 million for Q3 2025 at KalVista Pharmaceuticals, down from $3.4 million in the prior quarter.
- In the past five years, Exchange Rate Effect ranged from a high of $3.4 million in Q2 2025 to a low of -$628000.0 in Q2 2022.
- A 5-year average of $335722.2 and a median of $76000.0 in 2023 frame the typical range for Exchange Rate Effect.
- On a YoY basis, Exchange Rate Effect climbed as much as 8176.92% in 2022 and fell as far as 11200.0% in 2022.
- KalVista Pharmaceuticals' Exchange Rate Effect stood at -$13000.0 in 2021, then surged by 8176.92% to $1.0 million in 2022, then slumped by 157.33% to -$602000.0 in 2023, then soared by 167.61% to $407000.0 in 2024, then surged by 569.04% to $2.7 million in 2025.
- According to Business Quant data, Exchange Rate Effect over the past three periods registered $2.7 million, $3.4 million, and $407000.0 for Q3 2025, Q2 2025, and Q4 2024 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Exchange Rate Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 3.60 Mn |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | -2.70 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | -40.30 Mn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -900,000.00 |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | -7.06 Mn |
| 10 | KalVista Pharmaceuticals | 1.44 Bn | 1.25 Bn | 56.41 Mn | 2.72 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jul 31, 2025 | 2.72 Mn |
| Jul 31, 2025 | 2.72 Mn |
| Apr 30, 2025 | 3.36 Mn |
| Apr 30, 2025 | 3.36 Mn |
| Oct 31, 2024 | 407,000.00 |
| Oct 31, 2024 | 407,000.00 |
| Jul 31, 2024 | 117,000.00 |
| Jul 31, 2024 | 117,000.00 |
| Apr 30, 2024 | -74,000.00 |
| Apr 30, 2024 | -74,000.00 |
| Jan 31, 2024 | -621,000.00 |
| Jan 31, 2024 | -621,000.00 |
| Oct 31, 2023 | -602,000.00 |
| Oct 31, 2023 | -602,000.00 |
| Jul 31, 2023 | 84,000.00 |
| Jul 31, 2023 | 84,000.00 |
| Apr 30, 2023 | 68,000.00 |
| Apr 30, 2023 | 68,000.00 |
| Jan 31, 2023 | 457,000.00 |
| Jan 31, 2023 | 457,000.00 |
| Oct 31, 2022 | 1.05 Mn |
| Oct 31, 2022 | 1.05 Mn |
| Jul 31, 2022 | -339,000.00 |
| Jul 31, 2022 | -339,000.00 |
| Apr 30, 2022 | -628,000.00 |
| Apr 30, 2022 | -628,000.00 |
| Jan 31, 2022 | -523,000.00 |
| Jan 31, 2022 | -523,000.00 |
| Oct 31, 2021 | -13,000.00 |
| Oct 31, 2021 | -13,000.00 |
| Jul 31, 2021 | -3,000.00 |
| Jul 31, 2021 | -3,000.00 |
| Apr 30, 2021 | 85,000.00 |
| Apr 30, 2021 | 85,000.00 |
| Jan 31, 2021 | 491,000.00 |
| Jan 31, 2021 | 491,000.00 |
| Oct 31, 2020 | -319,000.00 |
| Oct 31, 2020 | -319,000.00 |
| Jul 31, 2020 | 254,000.00 |
| Jul 31, 2020 | 254,000.00 |
| Apr 30, 2020 | -236,000.00 |
| Apr 30, 2020 | -236,000.00 |
| Jan 31, 2020 | 190,000.00 |
| Jan 31, 2020 | 190,000.00 |
| Oct 31, 2019 | 802,000.00 |
| Oct 31, 2019 | 802,000.00 |
| Jul 31, 2019 | -494,000.00 |
| Jul 31, 2019 | -494,000.00 |
| Apr 30, 2019 | 64,000.00 |
| Apr 30, 2019 | 64,000.00 |
| Jan 31, 2019 | 618,000.00 |
| Jan 31, 2019 | 618,000.00 |
| Oct 31, 2018 | -731,000.00 |
| Oct 31, 2018 | -731,000.00 |
| Jul 31, 2018 | -1.16 Mn |
| Jul 31, 2018 | -1.16 Mn |
| Apr 30, 2018 | -571,000.00 |
| Apr 30, 2018 | -571,000.00 |
| Jan 31, 2018 | 2.56 Mn |
| Jan 31, 2018 | 2.56 Mn |
| Oct 31, 2017 | -69,000.00 |
| Oct 31, 2017 | -69,000.00 |
| Jul 31, 2017 | 64,000.00 |
| Jul 31, 2017 | 64,000.00 |
| Apr 30, 2017 | 100,000.00 |
| Apr 30, 2017 | 100,000.00 |
| Jan 31, 2017 | -82,000.00 |
| Jan 31, 2017 | -82,000.00 |
| Oct 31, 2016 | -737,000.00 |
| Oct 31, 2016 | -737,000.00 |
| Jul 31, 2016 | -440,000.00 |
| Jul 31, 2016 | -440,000.00 |